Duker Jay S.
Transaction: 07/10/2026
SELL
Change
-16,667
Price
Not reported
Filing
07/14/2026
Type
SELL
EyePoint Pharmaceuticals, Inc.
EYPT • Biotechnology
$4.58
▲ +0.01 (+0.33%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$396.37M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.07Healthy liquidity · 8.88Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:13 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.58
Change0.33%
Shares Out86.54M
Market Cap$396.37M
Enterprise Value$235.71M
52W Range9.65 - 19.11
Beta1.74
P/E-1.29
P/S142.12
P/B2.38
P/FCF-1.12
EV/Sales84.51
Price$4.58
Change0.33%
Shares Out86.54M
Market Cap$396.37M
Enterprise Value$235.71M
52W Range9.65 - 19.11
Beta1.74
P/E-1.29
P/S142.12
P/B2.38
P/FCF-1.12
EV/Sales84.51
EV/EBITDA-0.79
EV/FCF-0.67
Earnings Yield-77.36%
FCF Yield-89.01%
Dividend Yield0.00%
Gross Margin93.41%
Oper. Margin-7.76%
Profit Margin-7.39%
Debt/Eq0.07
Current Ratio8.88
Quick Ratio8.83
Target$18.29
Target Upside299.34%
Target Median$8.00
Target Range4.00 - 40.00
Volume2.24M
Avg Volume1.21M
EPS Surprise-0.20
Investment DNA
How strong this company looks for long-term investors
36
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
43/100
Why this score▼
Manageable debt level · 0.07Healthy liquidity · 8.88Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 20 analyst votes · 2026-09-05
83/100
Bullish
Bullish
13
Hold
7
Bearish
0
Price Target
2026-08-07
Low
$27.00
Mean
$35.33
Median
$39.00
High
$40.00
Insider Transactions
Recent executive and insider activity
Duker Jay S.
Transaction: 07/10/2026
SELL
Change
-8,059
Price
$14.72
Filing
07/14/2026
Type
SELL
Ribeiro Ramiro
Transaction: 06/30/2026
SELL
Change
-2,438
Price
$15.02
Filing
07/02/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Duker Jay S. | SELL | -16,667 | Not reported | 07/10/2026 | 07/14/2026 |
| Duker Jay S. | SELL | -8,059 | $14.72 | 07/10/2026 | 07/14/2026 |
| Ribeiro Ramiro | SELL | -2,438 | $15.02 | 06/30/2026 | 07/02/2026 |
| Ribeiro Ramiro | SELL | -2,438 | $8.26 | 06/30/2026 | 07/02/2026 |
| Elston George | SELL | -7,500 | Not reported | 05/25/2026 | 05/27/2026 |
| Elston George | SELL | -3,627 | $12.93 | 05/25/2026 | 05/27/2026 |
| Ribeiro Ramiro | SELL | -2,437 | $15.00 | 04/17/2026 | 04/20/2026 |
| Ribeiro Ramiro | SELL | -2,437 | $8.26 | 04/17/2026 | 04/20/2026 |
| Duker Jay S. | SELL | -52,500 | $13.13 | 03/23/2026 | 03/24/2026 |
| Duker Jay S. | SELL | -76,766 | $13.11 | 03/23/2026 | 03/24/2026 |
| Duker Jay S. | BUY | +1,500 | $13.15 | 03/16/2026 | 03/16/2026 |
| Elston George | BUY | +5,000 | Not reported | 03/02/2026 | 03/06/2026 |
| Ribeiro Ramiro | SELL | -2,438 | $17.87 | 03/04/2026 | 03/05/2026 |
| Ribeiro Ramiro | SELL | -2,438 | $8.26 | 03/04/2026 | 03/05/2026 |
| Ribeiro Ramiro | SELL | -2,437 | $15.00 | 02/17/2026 | 02/18/2026 |
| Ribeiro Ramiro | SELL | -2,437 | $8.26 | 02/17/2026 | 02/18/2026 |
| Elston George | SELL | -15,285 | Not reported | 01/06/2026 | 01/07/2026 |
| Elston George | SELL | -4,487 | $16.86 | 01/06/2026 | 01/07/2026 |
| Duker Jay S. | SELL | -20,793 | Not reported | 01/06/2026 | 01/07/2026 |
| Duker Jay S. | SELL | -10,054 | $16.86 | 01/06/2026 | 01/07/2026 |